May Measurement Month 2023: results of an opportunistic blood pressure screening campaign in Paraguay
Clicks: 5
ID: 329761
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
1.2
/100
5 views
4 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #292 of 293 articles by views in European heart journal supplements : journal of the European Society of Cardiology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 293 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract The May Measurement Month (MMM) campaign was conducted in Paraguay in 2023 to raise awareness of elevated blood pressure (BP). Adults aged ≥18 years were recruited through convenience sampling at 175 screening sites in 18 Health Regions across the country, and data were collected by 54 trained healthcare volunteers. Three seated BP readings were taken from each participant, and a questionnaire collected information on demographics, lifestyle factors, and comorbidities. Hypertension was defined as a systolic BP ≥140mmHg or a diastolic BP ≥90mmHg, or being on BP-lowering medication. Controlled BP was defined as being on BP-lowering medication with a BP <140/90mmHg. Multiple imputation was used to estimate missing BP readings. In total, 7,373 adults were screened, with a mean age of 47.0 years and 62.1% were female. Of all participants, 4,072 (55.2%) had hypertension, of whom 3,009 (73.9%) were aware, and 2,912 (71.5%) were on antihypertensive medication. Of those on antihypertensive medication, 1,274 (43.8%) had controlled BP, and of all participants with hypertension, 31.3% had controlled BP. Of those on BP-lowering medication, 47.5% were taking only one pharmacologic agent. Male participants showed lower awareness of high BP, were less likely to use BP-lowering medication, and exhibited poorer BP control. The MMM campaign identified a substantial number of participants with untreated or inadequately treated hypertension. These findings emphasise the need to strengthen prevention, early detection, effective treatment, and public health policies to improve patient outcomes.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (95 words).
Try re-searching for a better abstract.
| Reference Key |
openalex_W7214332481
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Abdón Villamayor, Rocío Aparicio, José Ortellado, Manuel Castillo, Victoria Chaparro, Thomas E Beaney, Gabriele Keziah Kerr, Graciela González |
| Journal | European heart journal supplements : journal of the European Society of Cardiology |
| Year | 2026 |
| DOI |
10.1093/eurheartjsupp/suag101
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.